Laparoscopic vertical sleeve gastrectomy for morbid obesity. The future procedure of choice?

被引:98
作者
Frezza, Eldo E. [1 ]
机构
[1] Texas Tech Univ, Hlth Sci Ctr, Dept Surg, Div Gen Surg, Lubbock, TX 79415 USA
关键词
sleeve gastrectomy; partial gastrectomy; morbid obesity; restrictive procedure; gastroplasty; laparoscopy; PLASMA GHRELIN LEVELS; ASSISTED DISTAL GASTRECTOMY; EARLY GASTRIC-CANCER; HIGH-RISK PATIENTS; BARIATRIC OPERATION; DUODENAL SWITCH; WEIGHT-LOSS; SURGERY; SOMATOSTATIN; SUCCESS;
D O I
10.1007/s00595-006-3407-2
中图分类号
R61 [外科手术学];
学科分类号
摘要
I report the general experience of performing sleeve gastrectomy defined as "a partial gastrectomy that results in removal of most of the stomach," as a first-stage procedure for morbidly and super-obese people. I also explore its potential as a single procedure evaluating its advantages and disadvantages. This procedure is designed to reduce the size of the stomach and its distention, whereby the patient feels full sooner and their appetite is decreased. Some posit-increased satiety results from the decreased ghrelin, secreted by the fundus, which is resected during this procedure. The advantages of sleeve gastrectomy are as follows: the stomach is reduced without loss of function, pyloric preservation prevents dumping, it requires only 1 day in the hospital, it provides an effective first-stage procedure for super-obese patients, it is useful in patients with disorders such as anemia or Crohn's disease, which preclude intestinal bypass, it can be performed laparoscopically, even in patients who weigh over 500lbs, no band adjustment is required, it does not result in malabsorption, and it provides a good educational teaching base for doctors lacking experience in the treatment of gastric ulcers. The disadvantages include the risk of stapling complications and its irreversibility.
引用
收藏
页码:275 / 281
页数:7
相关论文
共 30 条
[1]  
ABDELMONEIM RI, 1985, INT SURG, V70, P101
[2]   Longitudinal gastrectomy as a treatment for the high-risk super-obese patient [J].
Almogy, G ;
Crookes, PF ;
Anthone, GJ .
OBESITY SURGERY, 2004, 14 (04) :492-497
[3]   Laparoscopic sleeve gastrectomy:: A multi-purpose bariatric operation [J].
Baltasar, A ;
Serra, C ;
Pérez, N ;
Bou, R ;
Bengochea, M .
OBESITY SURGERY, 2005, 15 (08) :1124-1128
[4]   Ghrelin secretion is inhibited by either somatostatin or cortistatin in humans [J].
Broglio, F ;
Van Koetsveld, P ;
Benso, A ;
Gottero, C ;
Prodam, F ;
Papotti, M ;
Muccioli, G ;
Gauna, C ;
Hofland, L ;
Deghenghi, R ;
Arvat, E ;
van der Lely, AJ ;
Ghigo, E .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (10) :4829-4832
[5]   Pre- and post-prandial plasma ghrelin levels do not correlate with satiety or failure to achieve a successful outcome after Roux-en-Y gastric bypass [J].
Christou, NV ;
Look, D ;
McLean, AP .
OBESITY SURGERY, 2005, 15 (07) :1017-1023
[6]   Decreased bleeding after laparoscopic sleeve gastrectomy with or without duodenal switch for morbid obesity using a stapled buttressed absorbable polymer membrane [J].
Consten, ECJ ;
Gagner, M ;
Pomp, A ;
Inabnet, WB .
OBESITY SURGERY, 2004, 14 (10) :1360-1366
[7]   Laparoscopic sleeve gastrectomy as an initial weight-loss procedure for high-risk patients with morbid obesity [J].
Cottam, D. ;
Qureshi, F. G. ;
Mattar, S. G. ;
Sharma, S. ;
Holover, S. ;
Bonanomi, G. ;
Ramanathan, R. ;
Schauer, P. .
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2006, 20 (06) :859-863
[8]   Are we closer to finding the treatment for type 2 diabetes mellitus in morbid obesity? Are the incretins the key to success? [J].
Frezza, EE .
OBESITY SURGERY, 2004, 14 (07) :999-1005
[9]  
FREZZA EE, 2007, DIG DIS SCI FEB
[10]  
FREZZA EE, UNPUB JSLS